Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall Hong Kong Standard 13h Moderna Pharma All sources
Merck KGaA spends $1.3bn to buy siRNA specialist Silence Therapeutics Pharmaceutical Technology 3d Silence Therapeutics Pharma Biotechnology All sources
Merck opens new semiconductor materials facility in Korea The Korea Times 1d Merck Pharma IT All sources
Merck and Moderna Prepare FDA Filing for Personalized mRNA Melanoma Vaccine Paired with Keytruda After Phase 3 Results Medical Daily 3d KEYTRUDA Moderna Pharma
Moderna stock plummets even after data confirm cancer vaccine with Merck met key endpoints in melanoma trial Boston Globe 1h Article paywall
Merck Foundation Chief Executive Officer (CEO), Senator Dr. Rasha Kelej and Kenya First Lady H.E. Mrs. Rachel Ruto, E.G.H. Officially Launched their Joint Programs at the Kenya State House African Press Organization 1h
Merck, Moderna Personalized mRNA Caner Vaccine Cuts Melanoma Recurrence Risk In Phase 3 Study RTT News 6h
Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall Hong Kong Standard 13h
